The Venture Codex Logo

The Venture Codex

Novalis LifeSciences

170 Commerce Way, Suite 200, Portsmouth, NH, 03801, United States

Overview

Venture capital firm focused on breakthrough life science technologies.

Founded

2017

Deals · 12mo

1

Links

WebsiteLinkedIn

Stage focus

Series B
Series C

Geographic focus

Belgium
Switzerland
United Kingdom
United States

Sector focus

—

Investment portfolio

18rounds
NAMEDATESIZE
Flywheel
Jan 2026Led
$28 MOther Equity
BlueWhale Bio
Sep 2023Participated
$18 MSeed
Flywheel
Jun 2023Led
$54 MSeries D
Mercy BioAnalytics
Apr 2023Led
$41 MSeries A
LevitasBio
Nov 2022Led
$35 MSeries C
Etherna
Aug 2022Led
$39 MSeries B
Animol Discovery
Jul 2022Led
$34 MSeries B
Enko Chem, Inc.
Jul 2022Participated
$70 MSeries C
Vizgen
Jun 2022Participated
$85 MSeries C
Sherlock Biosciences
Mar 2022Led
$80 MSeries B
Ori Biotech
Jan 2022Led
$100 MSeries B
AgBiome
Sep 2021Led
$116 MSeries D
Flywheel
Jan 2026Led
$28 MOther Equity
BlueWhale Bio
Sep 2023Participated
$18 MSeed
Flywheel
Jun 2023Led
$54 MSeries D
Mercy BioAnalytics
Apr 2023Led
$41 MSeries A
LevitasBio
Nov 2022Led
$35 MSeries C
Etherna
Aug 2022Led
$39 MSeries B
Animol Discovery
Jul 2022Led
$34 MSeries B
Enko Chem, Inc.
Jul 2022Participated
$70 MSeries C
Vizgen
Jun 2022Participated
$85 MSeries C
Sherlock Biosciences
Mar 2022Led
$80 MSeries B
Ori Biotech
Jan 2022Led
$100 MSeries B
AgBiome
Sep 2021Led
$116 MSeries D
18
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Novalis LifeSciences: 18 funding rounds are recorded in the selected participation categories.All available history.
Novalis LifeSciences: 18 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed01
Series A10
Series B53
Series C+42
Other Equity20

Monthly Deal Activity

Novalis LifeSciences: 18 deals are recorded across 82 months.All available history.
Novalis LifeSciences: 18 deals are recorded across 82 months. All available history
MonthDeals
Jan '201
Feb '200
Mar '201
Apr '200
May '200
Jun '203
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '211
May '210
Jun '210
Jul '210
Aug '210
Sep '211
Oct '210
Nov '210
Dec '210
Jan '221
Feb '220
Mar '221
Apr '220
May '220
Jun '221
Jul '222
Aug '221
Sep '220
Oct '220
Nov '221
Dec '220
Jan '230
Feb '230
Mar '230
Apr '231
May '230
Jun '231
Jul '230
Aug '230
Sep '231
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '261
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Novalis LifeSciences: Health & Life Sciences is the largest displayed sector by deal count (14 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Novalis LifeSciences: Health & Life Sciences is the largest displayed sector by deal count (14 deals). All available history
SectorDeals
Health & Life Sciences14
Food & Agriculture4
Networks, Cloud & Communication3
Data, Analytics & IT3
Space & Frontier Tech3
Crypto & Blockchain2
Government & Defense2
Manufacturing2
Media & Entertainment2
Real Estate & Construction2
Social & Community Platforms2

Deal Size Distribution

Novalis LifeSciences: 18 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Novalis LifeSciences: 18 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M2
$25M-$50M10
$50M-$100M4
$100M-$250M2
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Novalis LifeSciences: United States has the largest recorded deal count among the displayed regions (13 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Novalis LifeSciences: United States has the largest recorded deal count among the displayed regions (13 deals). All available history
RegionDeals
United States13
Europe5
Novalis LifeSciences: 20 co-investors are shown, with Anterra Capital sharing 3 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Novalis LifeSciences: 20 co-investors are shown, with Anterra Capital sharing 3 recorded deals. All available history
Co-investorShared deals
Anterra Capital3
EQT Life Sciences (LSP)3
Finistere Ventures3
Fund+3
Northpond Ventures3
Omega Funds3
PMV3
8VC2
ARCH Venture Partners2
Bill & Melinda Gates Foundation2
BNP Paribas Fortis Private Equity2
Germin8 Ventures2
Grand Decade2
Tao Capital Partners2
TO Ventures Food2
Yijing Capital2
Albany Capital1
Alumni Ventures1
Amadeus Capital Partners1
Beringea1

Investment Strategy

Novalis LifeSciences: Led accounts for 67% and participating for 33% of round participation.All available history.
Novalis LifeSciences: Led accounts for 67% and participating for 33% of round participation. All available history
CategoryDeals (count)Share (%)
Led1267%
Participating633%
Novalis LifeSciences: Single-lead accounts for 58% and co-led for 42% of lead dynamics.All available history.
Novalis LifeSciences: Single-lead accounts for 58% and co-led for 42% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead758%
Co-led542%

Team

Marijn Dekkers

Chairman/Founder

Paul Meister

Executive